Want to see JP:4926 full AI Analyst Report?
Top Page
C'BON COSMETICS Co., Ltd.
(4926)
Select Model
Select Model
Rating:61Neutral
Price Target:
¥1,271.00
▲(6.99% Upside)
Action:Reiterated
Date:05/18/26
The score is driven primarily by strong financial stability (very low leverage) and improving profitability, partially offset by historically volatile cash generation. Technical signals are weak (below key moving averages with negative MACD), and valuation signals are mixed due to a negative P/E and only a modest dividend yield.
Positive Factors
Balance sheet strength
Effectively zero debt and substantial equity provide durable financial flexibility. Low leverage reduces insolvency risk, allows the company to fund operations, absorb revenue dips, and invest in product or channel initiatives without relying on costly external financing.
Negative Factors
Volatile cash flow history
The historical swings in operating and free cash flow imply sensitivity to working capital and timing of receipts/payments. Such volatility undermines planning visibility, raises the chance of funding shortfalls in weaker periods, and makes sustained investment or dividend policies riskier.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance sheet strength
Effectively zero debt and substantial equity provide durable financial flexibility. Low leverage reduces insolvency risk, allows the company to fund operations, absorb revenue dips, and invest in product or channel initiatives without relying on costly external financing.
Read all positive factors
C'BON COSMETICS Co., Ltd. (4926) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥5.22B
Dividend Yield1.68%
Average Volume (3M)1.75K
Price to Earnings (P/E)24.3
Beta (1Y)0.19
Revenue Growth4.84%
EPS Growth57.41%
CountryJP
Employees694
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)58.92
Shares Outstanding4,281,200
10 Day Avg. Volume1,490
30 Day Avg. Volume1,753
Financial Highlights & Ratios
PEG Ratio0.44
Price to Book (P/B)0.94
Price to Sales (P/S)0.58
P/FCF Ratio9.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
C'BON COSMETICS Co., Ltd. Business Overview & Revenue Model
Company Description
C'BON COSMETICS Co.,Ltd. is engaged in the development and distribution of a diverse range of beauty products, encompassing conventional cosmetics, quasi-pharmaceuticals, and aesthetic devices. Its comprehensive product line includes essentials su...
How the Company Makes Money
The company primarily makes money by selling cosmetics and related beauty products to consumers. Revenue is generated mainly from: (1) Product sales: Sales of skincare-focused cosmetics (and associated beauty items) sold to customers through the c...
C'BON COSMETICS Co., Ltd. Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
86
Very Positive
Cash Flow
58
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.02B | 9.27B | 8.84B | 8.50B | 8.53B | 9.15B |
| Gross Profit | 6.91B | 7.03B | 6.74B | 6.40B | 6.34B | 7.10B |
| EBITDA | 426.60M | 454.62M | 292.59M | 168.63M | -92.22M | 329.61M |
| Net Income | 252.21M | 213.61M | 136.27M | -26.35M | -421.77M | 44.87M |
Balance Sheet | ||||||
| Total Assets | 8.67B | 8.60B | 8.60B | 8.81B | 8.84B | 9.56B |
| Cash, Cash Equivalents and Short-Term Investments | 2.54B | 3.02B | 2.65B | 3.63B | 3.98B | 2.80B |
| Total Debt | 0.00 | 0.00 | 0.00 | 4.24M | 13.27M | 22.30M |
| Total Liabilities | 3.00B | 2.91B | 2.89B | 3.15B | 3.13B | 3.36B |
| Stockholders Equity | 5.67B | 5.69B | 5.70B | 5.66B | 5.71B | 6.20B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 553.88M | -926.52M | -301.11M | -693.60M | 330.15M |
| Operating Cash Flow | 0.00 | 763.10M | -43.16M | 278.19M | -81.47M | 433.37M |
| Investing Cash Flow | 0.00 | -159.99M | -849.16M | -581.94M | 1.35B | 44.91M |
| Financing Cash Flow | 0.00 | -240.69M | -90.22M | -31.20M | -91.29M | -6.73M |
C'BON COSMETICS Co., Ltd. Technical Analysis
Positive
1188.00
Price Trends
1213.34
Positive
1256.85
Negative
1227.42
Negative
Market Momentum
-2.32
Negative
46.21
Neutral
34.05
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4926, the sentiment is Positive. The current price of 1188 is below the 20-day moving average (MA) of 1207.90, below the 50-day MA of 1213.34, and below the 200-day MA of 1227.42, indicating a neutral trend. The MACD of -2.32 indicates Negative momentum. The RSI at 46.21 is Neutral, neither overbought nor oversold. The STOCH value of 34.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4926.
C'BON COSMETICS Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ¥1.64B | 11.46 | ― | ― | -9.84% | ― | |
67 Neutral | ¥6.46B | 8.49 | ― | 2.38% | 0.66% | 31.88% | |
66 Neutral | ¥5.82B | 40.49 | ― | 1.59% | -6.94% | 251.44% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥5.22B | 24.35 | ― | 1.68% | 4.84% | 57.41% | |
58 Neutral | ¥7.98B | 44.07 | ― | 2.65% | 0.96% | -28.27% | |
52 Neutral | ¥5.33B | 21.23 | ― | ― | -18.19% | -65.57% |
* Consumer Defensive Sector Average
JP:4926
C'BON COSMETICS Co., Ltd.
1,220.00
111.58
10.07%
JP:4918
Ivy Cosmetics Corporation
289.00
-27.89
-8.80%
JP:4925
HABA Laboratories, Inc.
1,707.00
80.96
4.98%
JP:4929
ADJUVANT HOLDINGS CO., LTD.
724.00
-15.00
-2.03%
JP:4934
Premier Anti-Aging Co., Ltd.
611.00
-329.00
-35.00%
JP:4936
AXXZIA, Inc.
331.00
-135.08
-28.98%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.